Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Multicenter, Prospective Clinical Study, Measuring the Performance and Safety of the Surgical Hemostatic Agent "HEMOCOLLAGENE®" in Patients Requiring Oral Surgery

NCT05171231 is registered in ClinicalTrials.gov with Septodont as lead sponsor.

NCT NCT05171231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05171231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Multicenter, Prospective Clinical Study, Measuring the Performance and Safety of the Surgical Hemostatic Agent "HEMOCOLLAGENE®" in Patients Requiring Oral Surgery
Lead sponsor
Septodont
Phase
Observational
Overall status
Completed
Start date
November 3, 2021
Completion date
March 7, 2022
Enrollment
125 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

oral hemorrhage